Logo image
Stability of 3′-Deoxy-3′-[18F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time
Journal article   Open access   Peer reviewed

Stability of 3′-Deoxy-3′-[18F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time

Laura L Boles Ponto, Yusuf Menda, Kenneth Dornfeld, Timothy J Tewson, G. Leonard Watkins, John Sunderland, Michael M Graham and John Buatti
Cancer biotherapy & radiopharmaceuticals, Vol.25(3), pp.361-363
06/2010
DOI: 10.1089/cbr.2009.0709
PMCID: PMC2936251
PMID: 20578842
url
https://doi.org/10.1089/cbr.2009.0709View
Published (Version of record) Open Access

Abstract

The purpose of this study was to evaluate the consistency of 3′-deoxy-3′[ 18 F]fluorothymidine (FLT) standardized uptake values (SUVs) over the time course of imaging in head and neck cancer. Thirteen (13) subjects (all male; age: 56.9 ± 6.7 years) with squamous cell head and neck cancer, stage III/IV, were administered FLT and imaged dynamically for 1 hour over the tumor and then underwent whole-body (WB) imaging commencing at 74 ± 6 minutes. Imaging was repeated after 5 days of radiotherapy (10 Gy) and a single course of platinum-based chemotherapy. Volumes-of-interest (VOIs) were created on the last dynamic frame (SUV 60 ). The pretherapy WB and midtherapy images were coregistered to the dynamic sequence and VOIs were applied. Mean and maximum SUVs (SUV 60 and SUV WB ) and the change with treatment were evaluated. The correlations (Spearman's ρ ) between SUV 60 and SUV WB for all VOIs (pre- and midtherapy, n  = 108 data pairs) were 0.98 for mean and 0.97 for maximum SUVs ( p  < 0.0001). Average absolute differences between SUV 60 and SUV WB were 0.18 ± 0.15 and 0.29 ± 0.32 SUV units, respectively. Correlations (Spearman's ρ ) between the change in SUV with therapy were 0.90 for mean and 0.89 for maximum SUV ( p  < 0.0001), with differences in the change values averaging 0.03 ± 0.36 and −0.17 ± 0.57 units, respectively. FLT SUVs are stable and comparable for images initiated between 55 and 100 minutes postinjection whether acquired pre- or midtherapy in head and neck cancer.
Short Communications standardized uptake values head and neck cancer [18F]fluorothymidine FLT

Details

Metrics

Logo image